- Di sistema
- The congress aims to review the current state of the art regarding the use of biomarkers in prostate, renal, bladder and urinary tract cancers, with a specific focus on the most recent advances in research in this field and on the evaluation of future development strategies to better integrate laboratory findings and clinical practice in the management of these tumours.
As such, the meeting is primarily intended for physicians and other healthcare professionals with a specific interest in biomarkers and/or urological malignancies.